Atlas Trials

Huahui Health

17 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Huahui Health

RecordFirmDate
A First-in-Human Study of HH160 in Patients With Advanced Solid Tumors (NCT07623369)Huahui Health2026-06-01
A Phase Ib/II Trial to Evaluate the Efficacy and Safety of HH-009 for the Treatment of FGF19-positive Advanced or Unresectable HCC (NCT07547553)Huahui Health2026-05-19
Clinical Study to Evaluate the Efficacy and Safety of HH-006 in Patients With Chronic Hepatitis B Virus Infection (NCT07519330)Huahui Health2026-05-14
A Phase III Study to Evaluate the Efficacy and Safety of Libevitug in Participants With Chronic HDV Infection (D-clear Study) (NCT07499544)Huahui Health2026-04-22
A Study to Assess Efficacy and Safety of HH-003 Injection in Subjects With Chronic Hepatitis Delta Virus Infection (NCT05861674)Huahui Health2023-06-16
HH-120 Nasal Spray for Post-exposure Prevention of SARS-CoV-2 (NCT05787418)Huahui Health2023-03-31
A Study To Assess The Efficacy and Safety of HH-120 Nasal Spray for the Treatment of Mild COVID-19 (NCT05713318)Huahui Health2023-01-18
A Study to Evaluate the Safety and Pharmacokinetics of HH-120 Nasal Spray in Healthy Volunteers (NCT05753878)Huahui Health2022-11-08
A Study to Evaluate the Antiviral Activity and Safety of HH-003 in Chronic Hepatitis B Subjects With Low-level Viremia (NCT05734807)Huahui Health2022-07-20
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HH-006 in Healthy Volunteers (NCT05275465)Huahui Health2022-05-03
A Study to Assess the Safety, Tolerability and Preliminary Efficacy of HH-120 for the Treatment of COVID-19 (NCT06039163)Huahui Health2022-04-16
A Phase 1 Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HH-101 in Patients With Advanced Solid Tumors (NCT07554196)Huahui Health2022-01-19
A Study to Assess the Safety, Tolerability and Pharmacokinetics of Inhaled HH-120 Aerosol in Healthy Volunteers (NCT05116865)Huahui Health2021-11-01
A Study to Evaluate the Antiviral Activity and Safety of HH-003 Injection in Subjects With HBeAg-Negative Chronic Hepatitis B Treated With Nucleos(t)Ide Reverse Transcriptase Inhibitors (NCT05839639)Huahui Health2021-10-09
A Study to Evaluate the Antiviral Activity and Safety of HH-003 Injection in Subjects With Chronic Hepatitis B and Hepatitis D Co-infection (NCT05674448)Huahui Health2021-08-11
A Study to Evaluate the Safety, Tolerability of HH-003 Injection in Participants With Chronic Hepatitis B Virus Infection (NCT05542979)Huahui Health2019-08-05

Track Huahui Health automatically

Every clearance here is in the API, with alerts when new ones post.